Babak Azad Net Worth

The estimated Net Worth of Babak Azad is at least $382 Thousand dollars as of 8 June 2023. Mr Azad owns over 20,401 units of GoodRx stock worth over $382,439 and over the last 4 years he sold GDRX stock worth over $0.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

or

Sign up with Google Sign up with Facebook

Mr Azad GDRX stock SEC Form 4 insiders trading

Mr has made over 18 trades of the GoodRx stock since 2021, according to the Form 4 filled with the SEC. Most recently he exercised 20,401 units of GDRX stock worth $152,803 on 8 June 2023.

The largest trade he's ever made was exercising 70,833 units of GoodRx stock on 1 June 2021 worth over $420,748. On average, Mr trades about 20,327 units every 42 days since 2021. As of 8 June 2023 he still owns at least 51,060 units of GoodRx stock.

You can see the complete history of Mr Azad stock trades at the bottom of the page.

Mr. Babak Azad biography

Babak Azad is the Chief Marketing Officer and SVP of Marketing & Communications at GoodRx.

How old is Mr Azad?

Mr Azad is 47, he's been the Chief Marketing Officer and SVP of Marketing & Communications of GoodRx since . There are 4 older and 2 younger executives at GoodRx. The oldest executive at GoodRx Holdings, Inc. is Bansi Nagji, 56, who is the Pres of Healthcare.

What's Mr Azad's mailing address?

Babak's mailing address filed with the SEC is C/O GOODRX HOLDINGS, INC., 2701 OLYMPIC BOULEVARD, SANTA MONICA, CA, 90404.

Insiders trading at GoodRx

Over the last 4 years, insiders at GoodRx have traded over $678,425,284 worth of GoodRx stock and bought 1,817,103 units worth $61,013,097 . The most active insiders traders include Capital Management, Llc Abd..., Men, Llc Idea, and Stephen Spectrum Vii Invest.... On average, GoodRx executives and independent directors trade stock every 11 days with the average trade being worth of $1,330,718. The most recent stock trade was executed by Romin Nabiey on 8 September 2024, trading 12,433 units of GDRX stock currently worth $93,123.

What does GoodRx do?

GoodRx Holdings, Inc., through its subsidiaries, provides information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices through GoodRx codes that are used to save money on prescriptions across the United States. It also offers other healthcare products and services, including telehealth services. The company serves pharmacy benefit managers that manage formularies and prescription transactions, including establishing pricing between consumers and pharmacies. GoodRx Holdings, Inc. was incorporated in 2015 and is based in Santa Monica, California.

Complete history of Mr Azad stock trades at GoodRx

GoodRx executives and stock owners

GoodRx executives and other stock owners filed with the SEC include:

• Trevor Bezdek,
  Co-founder, Co-CEO, Sec. & Director
• Douglas Joseph Hirsch,
  Co-founder, Co-CEO & Director
• Bansi Nagji,
  Pres of Healthcare
• Andrew Slutsky,
  Pres of Consumer
• Justin Fengler,
  Sr. VP of Corp. Strategy & Bus. Operations
• Karsten Ian Voermann,
  Chief Financial Officer
• Whitney Notaro,
  VP of Investor Relations
• Karsten Voermann,
  Chief Financial Officer
• Babak Azad,
  Chief Marketing Officer and SVP of Marketing & Communications
• Douglas Joseph Hirsch,
  Chief Mission Officer
• Romin Nabiey,
  Chief Accounting Officer
• Men, Llc Idea,
  10% owner
• Stephen Spectrum Vii Invest...,
  
• Jacqueline B Kosecoff,
  Director
• Lake Group, L.L.C.Slta V (G...,
  
• Ian T Clark,
  Director
• Capital Management, Llc Abd...,
  
• Andrew Slutsky,
  President, Consumer
• Bansi Nagji,
  President, Healthcare
• Trevor Bezdek,
  Chairman
• Kelly J. Kennedy,
  Director
• Karsten Voermann,
  Chief Financial Officer
• Babak Azad,
  See Remarks
• Raj Beri,
  CHIEF OPERATING OFFICER
• Scott Wagner,
  See Remarks
• Equity Vii, L.P.Spectrum Vi...,
  
• Partners Iv, L.P.Francisco ...,
  
• Agnes Rey Giraud,
  Director
• Julie Mb Bradley,
  Director